Jin Medical International Ltd.

NasdaqCM:ZJYL Stock Report

Market Cap: US$320.9m

Jin Medical International Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Jin Medical International.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth17.5%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Jin Medical International Ltd.'s (NASDAQ:ZJYL) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Oct 30
Jin Medical International Ltd.'s (NASDAQ:ZJYL) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Some Confidence Is Lacking In Jin Medical International Ltd. (NASDAQ:ZJYL) As Shares Slide 31%

Sep 07
Some Confidence Is Lacking In Jin Medical International Ltd. (NASDAQ:ZJYL) As Shares Slide 31%

Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly

Aug 24
Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Jin Medical International Ltd. (NASDAQ:ZJYL) After Shares Rise 25%

Jul 24
Revenues Not Telling The Story For Jin Medical International Ltd. (NASDAQ:ZJYL) After Shares Rise 25%

Capital Allocation Trends At Jin Medical International (NASDAQ:ZJYL) Aren't Ideal

Jul 17
Capital Allocation Trends At Jin Medical International (NASDAQ:ZJYL) Aren't Ideal

Jin Medical International Ltd. (NASDAQ:ZJYL) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Jun 04
Jin Medical International Ltd. (NASDAQ:ZJYL) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Jin Medical International Ltd.'s (NASDAQ:ZJYL) Shares Climb 372% But Its Business Is Yet to Catch Up

Dec 27
Jin Medical International Ltd.'s (NASDAQ:ZJYL) Shares Climb 372% But Its Business Is Yet to Catch Up

What Jin Medical International Ltd.'s (NASDAQ:ZJYL) 69% Share Price Gain Is Not Telling You

Sep 29
What Jin Medical International Ltd.'s (NASDAQ:ZJYL) 69% Share Price Gain Is Not Telling You

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jin Medical International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqCM:ZJYL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2024203-10N/A
12/31/202320312N/A
9/30/202320333N/A
6/30/202320344N/A
3/31/202320344N/A
12/31/202220333N/A
9/30/202219322N/A
6/30/202220222N/A
3/31/202221222N/A
12/31/202121244N/A
9/30/202121366N/A
6/30/202120366N/A
3/31/202118377N/A
12/31/202017355N/A
9/30/202016223N/A
6/30/202017200N/A
3/31/2020173-3-3N/A
12/31/2019193-2-2N/A
9/30/2019204-1-1N/A
9/30/2018214-3-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ZJYL's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if ZJYL's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if ZJYL's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ZJYL's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if ZJYL's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ZJYL's Return on Equity is forecast to be high in 3 years time


Discover growth companies